Author Archives: Editor: BioPharm Physicians

Life Sciences in Massachusetts – A Governor and Investor’s Perspective

On July 16, 2016, a group of 85 senior physician executives from the Boston area biotech and pharmaceutical industry gathered at Alnylam Pharmaceuticals in Cambridge to hear Deval Patrick, former Governor of Massachusetts and Managing Director of Bain Capital, discuss …

Posted in Blog | Leave a comment

Drug Pricing & Reimbursement

On May 14, 2015, 60 senior physician executives from the Boston area biotech and pharmaceutical industry gathered at Alnylam Pharmaceuticals in Cambridge to hear Julia Gaebler, Ph.D., Vice President, Health Advances and Troyen Brennan, M.D., M.P.H. EVP & CMO, CVS …

Posted in Blog | Leave a comment

Collaborating with Patient Advocacy Organizations in Drug Development

A panel of Patient Advocacy Organization leaders spoke to an audience of 65 senior physician executives from the Boston CMO Network on Dec 2, 2014. The event was moderated by Matt Sherman, MD, CMO of Acceleron and hosted by Biogen …

Posted in Blog | Leave a comment

FDA Perspective on Rare Diseases

Rich Moscicki, M.D., Deputy Center Director for Science Operations, FDA spoke to an audience of 75 senior physician executives from the Boston CMO Network on April 7, 2014.  The event was hosted by Sarepta Therapeutics at the company’s new headquarters …

Posted in Blog | Leave a comment

Hot Topics in Drug Development: The EMA perspective

Dr. Hans-Georg Eichler spoke to an audience of 55 senior physician executives from the Boston CMO Network on Sep 17, 2013. The event was hosted by Genyme Corporation in Cambridge, MA. Dr. Eichler discussed four topics in his prepared remarks: …

Posted in Blog | Leave a comment

Three New FDA Initiatives that Matter

Dr. Janet Woodcock spoke to an audience of 75 senior physician executives from the Boston CMO Network on May 6, 2013. The event was hosted by Alnylam Pharmaceuticals in Cambridge, MA. Dr. Woodcock focused her prepared remarks on three topics. …

Posted in Blog | Leave a comment

Creating Efficiencies in Clinical Trial Design – Dr. Robert Temple, FDA, CDER

On March 1st, the Boston CMO Network sponsored its second event. Dr. Robert Temple, presented to a group of 80 physician executives from Boston area biotech and pharmaceutical companies on the topic of “Creating Efficiencies in Clinical Trial Design”. Dr. …

Posted in Blog | Leave a comment

The Boston CMO Network

“We are rapidly becoming the major biotech/pharma hub in the US.  As senior medical leaders, we should be meeting to discuss critical industry issues, network, and expand our horizons beyond the day-to-day activities in our respective organizations.  We can learn …

Posted in Blog | Leave a comment